Form 4: Corcept Therapeutics Executive Sean Maduck Reports Stock Sale
SEC Form 4
Sean Maduck, President of Corcept Endocrinology, reports the sale of 1,697 shares of Corcept Therapeutics stock at $60.58 per share, alongside the exercise of stock options.
Summary
- Sean Maduck, President of Corcept Endocrinology at Corcept Therapeutics, filed a Form 4 detailing changes in beneficial ownership.
- On March 24, 2025, Maduck exercised stock options to acquire 1,697 shares at $5.05 per share.
- Simultaneously, Maduck sold 1,697 shares at $60.58 per share.
- Following these transactions, Maduck directly owns 85,622 shares and indirectly owns 10,000 shares through Duckhill Capital, LLC and 10,000 shares through Sean and Molly Maduck Living Trust.
- The sale was executed under a pre-arranged 10b5-1 trading plan adopted on September 5, 2024.
Sentiment
Score: 5
Explanation: The sentiment is neutral as the filing represents a routine transaction under a pre-existing trading plan. It doesn't necessarily indicate a positive or negative outlook on the company.
Industry Context
Form 4 filings are routine disclosures required by the SEC to provide transparency into the transactions of company insiders. These filings are closely watched by investors to gauge management's sentiment and confidence in the company's prospects.
Stakeholder Impact
- The stock sale by an executive could be perceived neutrally by stakeholders as it was executed under a pre-arranged trading plan.
Key Dates
| Date | Description |
|---|---|
| 09/05/2024 | Date of adoption of 10b5-1 trading plan. |
| 09/03/2024 | Grant date of restricted stock awards, 458 shares. |
| 12/02/2024 | Grant date of restricted stock awards, 265 shares. |
| 03/03/2025 | Grant date of restricted stock awards, 266 shares. |
| 03/24/2025 | Date of stock option exercise and sale. |
| 03/26/2025 | Date of Form 4 filing. |
| 05/02/2026 | Expiration date of stock options. |
Keywords
Form 4, Beneficial Ownership, Stock Sale, Stock Options, Corcept Therapeutics, CORT, Sean Maduck, 10b5-1 plan
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.